Wall Street analyst estimates for CVRx, Inc. (CVRX): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often referred to as systolic heart failure.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 5 |
| Hold | 1 |
| Sell | 1 |
| Strong Sell | 0 |
| Total analysts | 7 |
| Avg rating (1-5) | 0.57 |
Valuation Ratios
| Price / Book | 3.99 |
| EV / EBITDA | -1.68 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $6.3M | $6.1M | $13.0M | $22.5M | $39.3M | $51.3M | $56.7M |
| Cost of Revenue | $1.7M | $1.4M | $3.6M | $5.0M | $6.3M | $8.3M | $8.3M |
| Gross Profit | $4.6M | $4.6M | $9.4M | $17.5M | $33.0M | $43.0M | $48.3M |
| Research & Development | $8.7M | $6.4M | $7.5M | $10.0M | $11.6M | $11.1M | $11.1M |
| Selling, General & Admin | $6.1M | $9.7M | $27.9M | $50.0M | $64.5M | $91.3M | $88.5M |
| Operating Expenses | $14.8M | $16.1M | $35.4M | $60.0M | $76.1M | $102.4M | $99.6M |
| Operating Income | -$10.2M | -$11.5M | -$26.0M | -$42.5M | -$43.1M | -$59.5M | -$51.3M |
| EBITDA | -$12.8M | -$11.5M | -$40.6M | -$40.7M | -$38.7M | -$54.9M | -$46.7M |
| Interest Expense | $1.7M | $2.5M | $2.2M | $165000 | $1.8M | $4.4M | $5.8M |
| Pre-tax Income | -$14.6M | -$14.0M | -$43.0M | -$41.3M | -$41.1M | -$59.9M | -$53.3M |
| Income Tax | $73000 | $85000 | $91000 | $109000 | $147000 | $55000 | -$18000 |
| Net Income | -$14.6M | -$14.1M | -$43.1M | -$41.4M | -$41.2M | -$60.0M | -$53.3M |
| EPS | $-0.76 | $-0.73 | $-2.11 | $-2.02 | $-1.99 | $-2.65 | $-2.04 |
| EPS (Diluted) | $-0.76 | $-0.73 | $-2.11 | $-2.02 | $-1.99 | $-2.65 | $-2.04 |
| Shares Outstanding (Diluted) | $482581 | $387083 | $20.7M | $20.5M | $20.8M | $22.6M | $26.1M |
Price
| Price | $3.02 |
| Market Cap | $80M |
| Exchange | NASDAQ |
| Country | US |
Related companies: CERS · MASS · NNOX · OMI · PRQR · QTRX · SENS
Explore sector: Healthcare · Medical - Devices
More sections of CVRX: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks